Highlights CS MEDICA A/S

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
4.901 ^DKK	-2.49%		-8.58%	+4.66%

May. 23	Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024
May. 17	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	Apr. 30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	Apr. 22	CI
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	Apr. 04	CI
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	Feb. 20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	Feb. 02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	Jan. 26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	Dec. 27	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	23-10-31	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	23-10-12	CI
CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-09-13	CI
CS Medica Secures Denmark Patent for Nasal Spray	23-08-30	MT
CS MEDICA A/S Announces Establishment of CANNORDIC India Pvt. Ltd. to Expand Presence in India	23-07-14	CI
CS Medica A/S Signs New Own-Label Agreement on Pain Patch	23-06-21	CI
CS Medica Signs Deal for Future Compliance for CE-marked Medical Devices with CBD in EU	23-06-15	MT
CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body	23-06-15	CI
CS Medica A/S Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis	23-05-08	CI
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-04-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CS MEDICA A/S

Equities

CSMED

DK0061668225

Highlights

Filters